Concepedia

Lenny Dang

LD

Statistics

Publications

40

Citations

13.4K

H-Index

33

Active since

2002

Affiliations

Agios Pharmaceuticals (United States)(Current)

Millennium Engineering and Integration (United States)

National Institutes of Health

Harvard University

National Cancer Institute

Lenny Dang is an author at Agios Pharmaceuticals (United States) specializing in molecular oncology, medicine, and oncology.

Publications per year

2002–2023

40

Publications

40

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4.1K citations · Full text

Medicine, Genetics, Molecular Genetics +10

Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

Christina M. Annunziata, R. Eric Davis, Yulia N. Demchenko et al. · Cancer Cell · 2007 · 949 citations · Full text

Medicine, Genetics, Molecular Biology +13

NF-κB as a Therapeutic Target in Multiple Myeloma

Teru Hideshima, Dharminder Chauhan, Paul G. Richardson et al. · Journal of Biological Chemistry · 2002 · 892 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou, Yimin Yu, William J. Israelsen et al. · Nature Chemical Biology · 2012 · 825 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +15

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 797 citations

Medicine, Cancer Biology, Oncology +10

1–5 of 40